Author

HyonSu Jo

Observed name: Hyon-Su Jo

Institution: Pyongyang Medical University

Observed institutions: Dalian Medical University, Pyongyang Medical University, Second Affiliated Hospital of Dalian Medical University

ORCID: 0000-0003-4791-2173

Observed ORCID: 0000-0003-4791-2173

OpenAlex ID: A5021413549

Surgical treatment of locally advanced right colon cancer invading neighboring organs

2023 · HyokJu Ri, HaoNan Kang, et al. · Frontiers in Medicine · 18

Prognostic and Immunological Roles of CES2 in Breast Cancer and Potential Application of CES2-Targeted Fluorescent Probe DDAB in Breast Surgery

2023 · Weikun Qu, Yalu Yao, et al. · International Journal of General Medicine · 7

Broussoflavonol B induces S-phase arrest and apoptosis in pancreatic cancer cells by modulating the cell cycle checkpoint through inhibition of the AURKA/PLK1 pathway

2025 · HyokChol Choe, Zhen Wang, et al. · Cancer Cell International · 3

Neoadjuvant therapy for HER2-positive acantholytic squamous cell breast carcinoma: a case report

2023 · Jia Cong, HyonSu Jo, et al. · Journal of International Medical Research · 3

Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma

2023 · Jin-Shuai Guo, Hao Ding, et al. · Chinese Medical Sciences Journal · 3

Works count: 5

Citation count: 34

H-index: 3

I10-index: 1